SPARC0912
- Generic Name
- SPARC0912
Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open Angle GlaucomaOcular Hypertension
- Interventions
- Drug: Reference0912
- First Posted Date
- 2009-07-28
- Last Posted Date
- 2021-03-09
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Target Recruit Count
- 578
- Registration Number
- NCT00947661
- Locations
- 🇺🇸
SPARC study site, High Point, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath